Target intelligence / Profile preview

Deformed epidermal autoregulatory factor 1 transcription factor (DEAF1)

Target
DEAF1
Molecular classification
Transcription factor, Zinc finger protein, SAND domain-containing protein (SAND: SP100, AIRE-1, NucP41/75, DEAF-1), MYND domain-containing protein (MYND: Myeloid, Nervy, Deaf-1)
01

Overview

Deformed epidermal autoregulatory factor 1 transcription factor (DEAF1) is a multifunctional zinc finger, SAND and MYND domain-containing transcription factor[1][2][3]. It regulates transcription through direct DNA binding and protein-protein interactions. DEAF1 is crucial in embryonic development, central nervous system function (including serotonin receptor gene regulation), and immune response—especially in Drosophila, where it acts synergistically with other transcription factors to activate antimicrobial genes. In humans, DEAF1 modulates immune tolerance in lymph nodes and represses or enhances gene expression depending on the cellular context. Mutations in DEAF1 have been associated with cognitive disability, neurodevelopmental disorders, mood disease, and susceptibility to autoimmune conditions and osteoarthritis[2][3]. The gene exhibits alternative splicing resulting in multiple functional isoforms, and its activity is regulated by post-translational modifications such as phosphorylation[2].

Other names
NUDRSPNZMYND5MRD24SuppressinNuclear DEAF-1-related transcriptional regulatorZinc finger MYND domain-containing protein 5
02

Mechanism of action

Not applicable, as there are no known interacting drugs. Mechanistic research has focused on how DEAF1 regulates transcription rather than drug-mediated modulation[2].

03

Biological functions

Regulation of gene transcriptionRegulation of embryonic developmentModulation of serotonergic neurotransmission (repression/enhancement of serotonin 1A receptor gene in brain)Control of immune response genes (synergizes with Rel and GATA factors to induce antimicrobial peptide genes in Drosophila)Regulation of tissue-specific antigen expression and maintenance of immune toleranceChromatin remodeling and promoter binding
04

Disease associations

Cognitive disability/intellectual disabilityBehavioral disturbances, mood disorders (depression, anxiety, suicidal behavior)Osteoarthritis susceptibility (via GDF5 regulation)Potential contribution to autoimmune diseases (via antigen regulation in lymph nodes)Neurodevelopmental disordersOther (role in innate immunity in Drosophila)
05

Safety considerations

Direct drug targeting of transcription factors like DEAF1 is typically challenging due to poor specificity and potential off-target gene regulation.Mutations or altered function in DEAF1 can lead to severe neurodevelopmental, autoimmune, or psychiatric conditions, which complicates therapeutic approaches.
06

Biomarkers

Mutations in DEAF1 (especially in the SAND domain) are biomarkers for intellectual and cognitive disability, and behavioral disorders.Expression of DEAF1 or its splice variants may be relevant in autoimmune pathogenesis and could theoretically be monitored in research studies.

Beyond the preview

Go deeper on Deformed epidermal autoregulatory factor 1 transcription factor (DEAF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deformed epidermal autoregulatory factor 1 transcription factor (DEAF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call